Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry relief efforts for Katrina

This article was originally published in Pharmaceutical Approvals Monthly

Executive Summary

As of Sept. 9, member companies of the Pharmaceutical Research & Manufacturers of America donated $52.2 mil. in aid to areas affected by Hurricane Katrina, the organization reports. Among the contributions are a $5 mil. cash donation from Johnson & Johnson; $2.5 mil. from Amgen; $2 mil. from Pfizer; and $1 mil. or more from firms including Abbott, AstraZeneca, Merck and Wyeth. Nearly all of the companies participating in relief efforts also donated supplies and set up gift-matching programs. On the regulatory side, HHS opened the Strategic National Stockpile in order to supply vaccines and antibiotics. F-D-C Reports' parent company Reed Elsevier is making a $150,000 cash contribution...

You may also be interested in...



Industry Katrina aid update

PhRMA says its member companies have donated over $120 mil. in aid to areas affected by hurricane Katrina as of early October, up from $52.2 mil. as of Sept. 9 (1Pharmaceutical Approvals Monthly September 2005, In Brief). Top donors include Abbott, Amgen, J&J, Pfizer and Procter & Gamble. PhRMA notes it is joining forces with the Partnership for Prescription Assistance to provide access to free or nearly free drugs for underinsured, uninsured or low-income patients...

Sanofi, Long-Time Leader In Diabetes, Is Exiting Diabetes Research

The company's decision to exit diabetes research is not necessarily surprising given the development and commercial challenges in the therapeutic area, but it's not insignificant either.

QUOTED. 10 December 2019. Viral Shah.

The global insulin pump market is expected to see significant growth, reaching $5.1bn by 2023. A new Market Intel story looks at the competitive landscape of the three leading companies in this market, Medtronic, Insulet and Tandem Diabetes Care, which are all expected to launch new products in 2020. See what Viral Shah, an assistant professor of medicine and pediatrics at the University of Colorado, said about the diabetes market here.

Topics

UsernamePublicRestriction

Register

PS003038

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel